FY2025 · ended Dec 31, 2025 · Revenue $1.40M, -94.5% YoY · Filed Mar 18, 2026
Lifeward Ltd. (LFWD) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 million and a net loss of $19.9 million. Free cash flow was -$16.8 million. As of Jun 30, 2026 it held $9.4 million in cash and investments and $2.6 million in total debt.
Revenue (TTM)
$-8.65M
-135.4% vs year-ago TTM
Net income (TTM)
$-30.83M
-3.6% vs year-ago TTM
Operating cash flow (TTM)
$-17.08M
+4.4% vs year-ago TTM
Free cash flow (TTM)
$-17.10M
EPS (TTM)
$-17.07
-278.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
1.53M
-85.6% vs prior year
Net cash
$6.89M
as of Jun 30, 2026
Operating margin
263.1%
FY 2026
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- LFWD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Hudson, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1607962
- Former names
- ReWalk Robotics Ltd. (until Sep 16, 2024); Argo Medical Technologies Ltd. (until May 16, 2014)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.4M | $25.7M | $13.9M | $5.5M | $6.0M |
| Operating income | -$19.7M | -$29.3M | -$23.6M | -$19.1M | -$12.7M |
| Net income | -$19.9M | -$28.9M | -$22.1M | -$19.6M | -$12.7M |
| Diluted EPS | -$17.16 | -$39.96 | -$31.13 | -$2.20 | — |
| Operating cash flow | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M |
| Free cash flow | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M |
| Total assets | $22.9M | $30.5M | $63.2M | $74.2M | $94.8M |
| Total liabilities | $14.5M | $11.6M | $16.7M | $6.1M | $5.4M |
| Stockholders' equity | $8.4M | $18.8M | $46.5M | $68.2M | $89.4M |
| Cash and investments | $2.2M | $6.7M | $28.1M | $67.9M | $88.3M |
| Total debt | $1.6M | $880,000 | $1.9M | $897,000 | $1.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 8, 2026 | Oct 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2026 | Oct 1, 2026 |
| ARS | Annual report to shareholders | Sep 25, 2026 | Sep 25, 2026 |
| 8-K | Current report | Sep 15, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
All 862 Lifeward Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.